Mirror Exposure

We are examining the potential for an additive effect of a medication in mirror exposure treatment for body image disturbance in individuals with eating disorders. The medication, d-cycloserine, is an antibiotic shown to enhance learning in exposure treatments for anxiety disorders.

Participants are randomly assigned to receive d-cycloserine or a placebo. All participants complete 6 sessions: a baseline/psychiatric assessment, a psychoeducational session, a 4-week mirror exposure treatment and administration of placebo/study drug, and a 1 month follow up visit.

Compensation for participation will be $50.

If you would like more information or want to discuss participating, contact Sara Alavi at 212-659-9298 or via email at sara.alavi@mssm.edu

Mirror Exposure for Binge Eating and Bulimia Nervosa

We are examining whether incorporating acceptance-based mirror exposure (A-MET) into standard treatment for eating disorders enhances treatment outcome.

Participants aged 16-65 years old with eating disorders may be eligible to participate in this study.

Participation will consist of the following:

• Phase I: Randomization into Cognitive Behavioral Therapy-Enhanced (CBT-E) or Cognitive Behavioral Therapy- Guided Self-Help (CBT-GSH) for 10 weeks
• Phase II: Randomization into A-MET or Guided Self-Help Treatment for Body Shape and Weight Concerns
• 3- and 6-month follow ups

If you would like more information or want to discuss participating, contact Sara Alavi at 212-659-9298 or via email at sara.alavi@mssm.edu